MedTrace Logo

An Investigator Initiated Trial to Evaluate the Safety and Feasibility of the DyNETIC-35 Stent for Iliac Lesions Via a Trans-radial Approach

NCT05372952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-01-23

No results posted yet for this study

Summary

This feasibility study with a 30 day follow up period will assess the safety and feasibility of the Dynetic-35 stent for the treatment of peripheral iliac artery lesions via a trans-radial approach.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Dynetic-35 Peripheral Balloon-Expandable Stent System

Stenotic iliac lesions will be treated with the Dynetic 35 stent via a radial access

Sponsors & Collaborators

  • Klinikum Arnsberg

    lead OTHER

Principal Investigators

  • Michael H Lichtenberg, MD · Klinikum Hochsauerland GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2025-06-03
Completion
2025-06-03

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05372952 on ClinicalTrials.gov